| ID | 321 |
|---|
| No | 321 |
|---|
| Brand Name | HOVID TENOFOVIR DISOPROXIL FUMARATE TABLETS 300 MG |
|---|
| Ingredients | TENOFOVIR DISOPROXIL FUMARATE 300 MG |
|---|
| Dosage Form | FILM COATED TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 30'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR THE TREATMENT OF HIV-1 INFECTION IN COMBINATION WITH OTHER ANTIRETROVIRAL MEDICINAL PRODUCT FOR ADULTS, TREATMENT OF HIV-1 INFECTED ADOLESCENTS WITH NRTI RESISITANCE OR TOXICITIES PRECLUDING THE USE OF FIRST LINE AGENTS, AGED 12 TO <18 YEARS, FORO THE TREATMENT OF CHRONIC HEPATITIS B IN ADULT AND ADOLESCENT 12 - <18 YEARS OF AGE. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | WHITE, OBLONG, FILM COATED TABLET, EMBOSSED WITH QZ ON BOTH SIDES OF TABLETS |
|---|
| Note | |
|---|
| License Owner | BMS PHARMA SOLE CO.,LTD |
|---|
| Manufacturer | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO.,LTD |
|---|
| Country | CHINA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 01 I 5391/23 |
|---|
| FDD Registration Date | 23/01/2023 |
|---|
| Expiry Date | 22/01/2026 |
|---|
